Globus pallidus dopamine and Parkinson motor subtypes: Clinical and brain biochemical correlation

Neurology

Volumn 70, Issue 16 PART 2, 2008, Pages 1403-1410

  Rajput, A H ^a,c   Sitte, H H ^b   Rajput, A ^a   Fenton, M E ^a   Pifl, C ^b   Hornykiewicz, O ^b  

^a SASKATOON HEALTH REGION   (Canada)

^b Medical University of Vienna   (Austria)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; AUTOPSY; BIOCHEMISTRY; BRAIN REGION; BRAIN TISSUE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINE BRAIN LEVEL; FEMALE; FROZEN SECTION; GLOBUS PALLIDUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MOTOR DYSFUNCTION; MOTOR UNIT; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; TREMOR;

EID: 42049097441     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000285082.18969.3a     Document Type: Article

References (54)

1. Rajput AH, Pahwa R, Pahwa P, Rajput A. Prognostic significance of the onset mode in parkinsonism. Neurology 1993;43:829-830.
2. Jankovic J, Rajput AH, McDermott MP, Perl DP, The Parkinson Study Group. The evolution of diagnosis in early Parkinson disease. Arch Neurol 2000;57:369-372.
3. Quinn N, Luthert P, Honavar M, Marsden CD. Pure akinesias due to Lewy body Parkinson's disease: a case with pathology. Mov Disord 1989;4:85-89.
4. Jellinger K. Pathology of parkinsonism. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. New York: Raven Press; 1986: 32-66.
5. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998;51(suppl 2):S2-S9.
6. Albin RL, Young AB, Penny JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
7. Wichmann T, DeLong MR. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol 2003;91:9-18.
8. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925-964.
9. Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. In: Yahr MD, Bergmann KJ, eds. Advances in neurology, Vol. 45. New York: Raven Press; 1986: 19-34.
10. Agid Y, Yavoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, and Fahn S, eds. Movement disorders. London: Butterworth; 1987: 166-230.
11. Nobin A, Bjõrklund A. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand 1973;388:1-40.
12. Cossette M, Levesque M, Parent A. Extrastriatal dopaminergic innervation of human basal ganglia. Neurosci Res 1999;34:51-54.
13. Hedreen JC. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol 1999;409:400-410.
14. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci 1991;18:275-278.
15. Rajput AH, Fenton ME, Birdi S, et al. Clinical-pathological study of levodopa complications. Mov Disord 2002;17:289-296.
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
17. Webster DD. Critical analysis of disability in Parkinson's disease. Mod Treat 1968;5:257-282.
18. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information; 1987: 153-305.
19. Felice LJ, Felice JD, Kissinger PT. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 1978;31:1461-1465.
20. Sperk G. Simultaneous determination of serotonin, 5-hydroxyindole acetic acid, 3,4-dihydroxypehenylacetic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection. J Neurochem 1982;38:840-843.
21. Pifl C, Bertel O, Schingnitz G, Hornykiewicz O. Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP). Neurochem Int 1990;17:263-270.
22. Björklund A, Lindvall O. Dopamine-containing systems in the CNS. In: Bjorklund A, Hokfelt T, eds. Classical transmitters in the CNS. Amsterdam: Elsevier; 1984: 55-122.
23. Lewis DA, Sesack SR. Dopamine systems in the primate brain. Handbook of chemical neuroanatomy, volume 13: the primate nervous system, part I. Amsterdam: Elsevier; 1997.
24. Hauber W. Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav Brain Res 1999;106:143-150.
25. Fuchs H, Nagel J, Hauber W. Effects of physiological and pharmacological stimuli on dopamine release in the rat globus pallidus. Neurochem Int 2005;47:474-481.
26. Ploska A, Taquet H, Javoy-Agide F, et al. Dopamine and methionine-enkephalin in human brain. Neurosci Lett 1982;33:191-196.
27. Hõrtnagl H, Schlögl E, Sperk G, Hornykiewicz O. The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain. Prog Brain Res 1983;58:269-274.
28. Hornykiewicz O. Zur Existenz "dopaminerger" Neurone im Gehirn. Arch Exp Path Pharmak 1964;247:304.
29. Arai H, Kosaka K, Iizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem 1984;43:388-393.
30. Hazrati LN, Parent A. The striatopallidal projection displays a high degree of anatomical specificity in the primate. Brain Res 1992;592:213-227.
31. Gaspar P, Berger B, Alvarez C, Vigny A, Henry JP. Catecholaminergic innervation of the septal area in man: immunocytochemical study using TH and DBH antibodies. J Comp Neurol 1985;241:12-33.
32. Jan C, Chantal F, Tande D, et al. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur J Neurosci 2000;12:4525-4535.
33. Hornykiewicz O, Lisch HJ, Springer A. Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres. Brain Res 1968;11:662-671.
34. Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in human brain: their behaviour in extrapyramidal system diseases. Klin Wochenschr 1960;38:1236-1239.
35. Bernheimer H, Birkmayer W, Hornykiewicz O. Zur Biochemie des Parkinson-Syndrome des Menschen. Klin Wschr 1963;41:465-469.
36. Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 1991;44:591-605.
37. Whone AL, Moore RY, Piccini PP, Brooks DJ. Plasticity of the Nigropallidal Pathway in Parkinson's Disease. Ann Neurol 2003;53:206-213.
38. Grabli D, McCairn K, Hirsch EC, et al. Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain 2004;127:2039-2054.
39. François C, Grabli D, McCairn K, et al. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study. Brain 2004;127:2055-2070.
40. DeLong MR. Activity of basal ganglia neurons during movement. Brain Res 1972;40:127-135.
41. Hassler R, Riechert T, Mundinger F, Umbach W, Ganglberger JA. Physiological observations in stereotaxic operations in extrapyramidal motor disturbances. Brain 1960;83:337-350.
42. Smith Y, Parent A. Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri sciureus). Neuroscience 1986;18:347-371.
43. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci 1990;13:254-258.
44. Hutchison WD, Lozano AM, Tasker RR, Lang AE, Dostrovsky JO. Identification and characterization of neurons with tremor-frequency activity in human globus pallidus. Exp Brain Res 1997;113:557-563.
45. De Bie RMA, Schuurman PR, de Haan PS, Bosch DA, Speelman JD. Unilateral pallidotomy in advanced Parkinson's disease: a retrospective study of 26 patients. Mov Disord 1999;14:951-957.
46. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
47. Vitek JL, Hashimoto T, Peoples J, DeLong MR, Bakay RAE. Acute stimulation in the external segment of the globus pallidus improves parkinsonian motor signs. Mov Disord 2004;19:907-915.
48. Stern G. Prognosis in Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders 2. London: Butterworth and Co. Ltd.; 1987: 91-98.
49. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;special suppl:78-89.
50. Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of parkinsonism with levodopa. Arch Neurol 1969;21:343-354.
51. Fazio C, Agnoli A, Casacchia M, Nardini M, Rettano M. Resultats de l'administration de Levo-Dopa per os. In: de Ajuriaguerra J, Gauthier G, eds. Monoamines, Noyaux Gris Centraux et Syndrome de Parkinson. Paris: Georg & Cie. Geneve and Masson & Cie; 1971: 418-428.
52. Markham CH. Thirty months' trial of levodopa in Parkinson's disease. Neurology 1972;22:17-21.
53. Ludin HP. Das Parkinsonsyndrom. 2nd edition. Berlin: W. Kohlhammer; 1995: 167.
54. Muenter M. Levodopa Ann Intern Med 1971;75:795-797.